Concentration of adipokines in peritoneal effluent: A new marker of acute peritonitis in peritoneal dialysis patients?

Peritoneal Dialysis International

Volumn 28, Issue 5, 2008, Pages 527-532

  Kolonko, Aureliusz ^a   Chudek, Jerzy ^a   Wiȩcek, Andrzej ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Adiponectin; Chronic kidney disease; Leptin; Peritonitis

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; C REACTIVE PROTEIN; LEPTIN; BIOLOGICAL MARKER;

ACUTE DISEASE; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; EFFLUENT; FEMALE; HEMODIALYSIS PATIENT; HUMAN; MALE; MICROBIOLOGICAL EXAMINATION; PERITONEAL DIALYSIS; PERITONITIS; PLEOCYTOSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; BLOOD; CASE REPORT; CHRONIC KIDNEY FAILURE; DIABETIC NEPHROPATHY; MIDDLE AGED; ROC CURVE;

ACUTE DISEASE; ADIPONECTIN; ADULT; AGED; BIOLOGICAL MARKERS; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; LEPTIN; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PERITONITIS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 58249086302     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080802800517     Document Type: Article

References (24)

1. Boeschoten EW, ter Wee PM, Divino J. Peritoneal dialysis-related infections recommendations 2005 - an important tool for quality improvement. Nephrol Dial Transplant 2006; 21(Suppl 2):31-3.
2. Van Biesen W, Veys N, Vanholder R, Lameire N. The role of APD in the improvement of outcomes in an ESRD program. Semin Dial 2002; 15:422-6.
3. Piraino B. Peritoneal dialysis infections recommendations. Contrib Nephrol 2006; 150:181-6.
4. Troidle L, Gorban-Brennan N, Kliger A, Finkelstein FO. Continuous peritoneal dialysis-associated peritonitis: a review and current concepts. Semin Dial 2003; 16:428-37.
5. Luo Q, Cheung AK, Kamerath CD, Reimer LG, Leypoldt JK. Increased protein loss during peritonitis associated with peritoneal dialysis is neutrophil dependent. Kidney Int 2000; 57:1736-42.
6. Ates K, Koc R, Nergizoglu G, Erturk S, Keven K, Sen A, et al. The longitudinal effect of a single peritonitis episode on peritoneal membrane transport in CAPD patients. Perit Dial Int 2000; 20:220-6.
7. Stefan N, Stumvoll M. Adiponectin - its role in metabolism and beyond. Horm Metab Res 2002; 34:469-74.
8. Don BR, Rosales LM, Levine NW, Mitch W, Kaysen GA. Leptin is a negative acute phase protein in chronic hemodialysis patients. Kidney Int 2001; 59:1114-20.
9. Chudek J, Adamczak M, Karkoszka H, Budzinski G, Ignacy W, Funahashi T, et al. Plasma adiponectin concentration before and after successful kidney transplantation. Transplant Proc 2003; 35:2186-9.
10. Kokot F, Adamczak M, Wiecek A. Plasma leptin concentration in kidney transplant patients during the early post-transplant period. Nephrol Dial Transplant 1998; 13: 2276-80.
11. Huang JW, Yen CJ, Chiang HW, Hung KY, Tsai TJ, Wu KD. Adiponectin in peritoneal dialysis patients: a comparison with hemodialysis patients and subjects with normal renal function. Am J Kidney Dis 2004; 43:1047-55.
12. Merabet E, Dagogo-Jack S, Coyne DW, Klein S, Santiago JV, Hmiel SP, et al. Increased plasma leptin concentration in end-stage renal disease. J Clin Endocrinol Metab 1997; 82:847-50.
13. Kagan A, Haran N, Leschinsky L, Shuali N, Rapoport J. Leptin in CAPD patients: serum concentrations and peritoneal loss. Nephrol Dial Transplant 1999; 14:400-5.
14. Heimburger O, Wang T, Lonnqvist F, Stenvinkel P. Peritoneal clearance of leptin in CAPD patients: impact of local insulin administration. Nephrol Dial Transplant 1999; 14: 723-7.
15. Zemel D, Betjes MG, Dinkla C, Struijk DG, Krediet RT. Analysis of inflammatory mediators and peritoneal permeability to macromolecules shortly before the onset of overt peritonitis in patients treated with CAPD. Perit Dial Int 1995; 15:134-41.
16. Oymak Y, Velioglu A, Haklar G, Ozener C, Yalcin AS. Early detection of peritonitis in continuous ambulatory peritoneal dialysis patients by cytokine measurements. Clin Chem Lab Med 2003; 41:640-5.
17. Ko YC, Mukaida N, Kasahara T, Muto S, Matsushima K, Kusano E, et al. Specific increase in interleukin-8 concentrations in dialysis fluid of patients with peritonitis receiving continuous ambulatory peritoneal dialysis. J Clin Pathol 1995; 48:115-19.
18. Brauner A, Hylander B, Wretlind B. Interleukin-6 and interleukin-8 in dialysate and serum from patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1993; 22:430-5.
19. Ikuta S, Ono S, Kinoshita M, Tsujimoto H, Yamauchi A, Mochizuki H. Interleukin-18 concentration in the peritoneal effluent correlates with the severity of peritonitis. Am J Surg 2003; 185:550-5.
20. Lai KN, Lai KB, Lam CW, Chan TM, Li FK, Leung JC. Changes of cytokine profiles during peritonitis in patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 2000; 35:644-52.
21. Mlambo NC, Hylander B, Brauner A. Increased levels of transforming growth factor beta 1 and basic fibroblast growth factor in patients on CAPD: a study during non-infected steady state and peritonitis. Inflammation 1999; 23:131-9.
22. Donovan KL, Pacholok S, Humes JL, Coles GA, Williams JD. Intra-peritoneal free elastase in CAPD peritonitis. Kidney Int 1993; 44:87-90.
23. Ruiz Solis S, Garcia Vicente A, Rodado Marina S, de la Torre M, Certes Romero M, Poblete Garcia V, et al. Diagnosis of the infectious complications of continuous ambulatory peritoneal dialysis by 99mTc-HMPAO labelled leukocytes [in Spanish]. Rev Esp Med Nucl 2004; 23:403-13.
24. Johnson G, Wilks M, Warwick S, Millar MR, Fan SL. Comparative study of diagnosis of PD peritonitis by quantitative polymerase chain reaction for bacterial DNA vs culture method. J Nephrol 2006; 19:45-9.